Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
12.93
-0.15 (-1.11%)
Dec 26, 2024, 4:00 PM EST - Market closed
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.10 billion as of December 27, 2024. Its market cap has decreased by -11.70% in one year.
Market Cap
1.10B
Enterprise Value
697.71M
1-Year Change
-11.70%
Ranking
Category
Stock Price
$12.93
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.10B, an increase of 428.88%. That is a compound annual growth rate of 20.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 1.12B | -25.87% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pediatrix Medical Group | 1.16B |
| CareDx | 1.15B |
| Enliven Therapeutics | 1.13B |
| Pulse Biosciences | 1.13B |
| Innoviva | 1.11B |
| ARS Pharmaceuticals | 1.11B |
| Ardelyx | 1.10B |
| Rocket Pharmaceuticals | 1.06B |